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Objective: Investigate long-term effects 4 years after the end of a 1-year self-management 
program (SMP) with 30 hours of education and 16 hours of physical activity in patients with 
chronic obstructive pulmonary disease (COPD).
Methods: Prospective observational outcome study. SMP focused on improving disease related 
self-care skills. Main outcome measures were health-related quality of life, HRQoL, (St Georges 
Respiratory Questionnaire, SGRQ total) and exercise capacity (6-minute walk test, 6MWT).
Results: Thirty patients participated, 47% women. Baseline mean age was 67 years and mean 
pre-bronchodilator FEV
1
 (forced expiratory volume in 1 second) percentage predicted was 
41.3. HRQoL showed a statistical significant improvement during the 1-year intervention. 
Four years after the end of the program SGRQ total was similar to baseline value, 1.4 points 
(95% CI: –3.6 to 6.3, P = 0.580). Also 6MWT was similar to baseline value at the same test 
point, –10 m (95% CI: –27 to 8, P = 0.262), and 63% reported having continued to exercise 
regularly a minimum of three times per week during the follow-up period.
Conclusion: The participants in a 1-year self-management program with additional training 
had maintained their pre-intervention level of HRQoL and exercise capacity 4 years after the 
end of the program. Two out of three participants had continued to exercise regularly.
Keywords: chronic obstructive pulmonary disease, outpatient, patient education, self-care 
ability, self-management
Introduction
Chronic obstructive pulmonary disease (COPD) is expected to be the third leading 
cause of death worldwide causing substantial health costs in 2020.1 Patients with 
COPD are anticipated to have a steady decrease in their health-related quality of life 
(HRQoL) and functional status.2 One intervention to increase the level of health of 
patients with COPD is self-management programs (SMP).3
SMPs aim to activate the participants and transfer as much as possible of the 
 management of living with COPD from the health care provider to the patients 
 themselves. This is helped by improving disease-related self-care skills and the patients’ 
use of relevant knowledge and coping strategies in real-life situations and to ensure 
maintenance after the program.3 According to Lorig and Holman4 the SMPs should 
focus on medical and/or behavioral management, role management, and emotional 
management in order to make the patients, as much as possible, independent in their 
way of handling their disease. Furthermore, in patients with COPD the importance of 
physical exercise as a part of successful rehabilitation is well documented.5–7
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A systematic review found a reduction in COPD-related 
hospital admissions, a significant reduction in dyspnea and 
small, but no clinically relevant improvements in HRQoL 
for patients with COPD participating in SMPs.8 However, 
the follow-up in the included studies was on the shorter 
side, ranging from 2 months to 1 year. As changes in patient 
health behavior requires time, there is a need for research 
on the long-term effect of SMPs. Benefits of pulmonary 
rehabilitation have been found to decline to pre-intervention 
levels during a 6–12 month period,9–11 which is probably a 
reason why adherence is said to be one of the most important 
challenges regarding rehabilitation.12 It is thus interesting 
to know whether SMPs help with maintaining exercise and 
health behavior at the end of these programs. The aim of 
the present study was therefore to investigate the long-term 
effects of a 1-year self-management program 4 years after 
the program ended.
Materials and methods
This was an open prospective observational outcome study 
conducted at an outpatient department in a hospital in Central 
Norway with intervention from January 2000 to February 
2002. The 5-year follow-up concluded in February 2006. The 
trial was performed according to the principles of the Helsinki 
declaration.13 All the participants were informed both orally 
and in writing, and gave written consent to participate.
Patients
Patients were included in the study if they had been given 
a diagnosis of COPD from their regular physician before 
entering SMP and had a pre-bronchodilator forced expira-
tory volume in 1 second (FEV
1
, forced expiratory volume in 
1 second; Spirobank G; Ocean WinSpiro, Rome, Italy) lower 
than 75% of the predicted. The participants had to have the 
ability to converse, no contraindications regarding physical 
activity, and not have been hospitalized in the past month. 
A post-bronchodilator spirometric test taken at baseline was 
retrospectively used to classify the disease severity among 
the participants based on the Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) criteria of 2007.14 To 
recruit participants, local general practitioners and health 
care personnel at the hospital were invited to refer patients 
to the program. All the patients invited agreed to participate 
in the project.
Intervention
The intervention is described in detail in a previous 
 publication.15 The self-management program was made up of 
16 gatherings, 46 hours counting 30 hours of education and 
16, 1-hour exercise sessions over 1 year. Twenty-four of the 
30 hours of educational sessions, and 12 of the 16 exercise 
sessions were carried out during the first 6 weeks. Patients 
were encouraged to continue to exercise  thereafter. The 
remaining hours of education and exercise were  accomplished 
at 12, 24, 36, and 48 weeks.
The educational program was based on patient perceived 
concerns and problems, as well as health care professionals’ 
experiences. The groups of five to seven patients were formed 
as the participants enrolled for the program, and neither age, 
gender, nor clinical picture were considered in the arrangement 
of the groups. The health care professionals participating in the 
delivery of the program comprised a physician, pharmacist, 
psychologist, nurse, social worker, physiotherapist, nutritionist, 
and occupational therapist. The principal aim of the program 
was to teach the participants basic problem-solving skills, 
this included problem definition and generation of possible 
solutions in dialog with the other participants and the health care 
professionals. From one lesson to the other, the participants set 
themselves short-term goals and reported the outcome in the 
group. In order to manage day-to-day decisions in response to 
changes in disease fluctuations, action plans were individually 
adjusted for all participants. The program also included how 
to self-treat with oral antibiotics and prednisolone. To help 
the participants make a better collaboration with their general 
practitioners, they learned how to report the trends of the 
disease and make informed choices about their medication. 
At the end of the educational sessions, all received a specially 
made booklet with a summary of the lectures. A physiotherapist 
trained in COPD care guided the 1-hour exercise sessions. 
Exercises were tailored to the individual, but performed in 
groups, and the instructor aimed to give every participant good 
experience of how to use their breathing during workout. 
Expected benefits from regular exercise were focused on in 
both the educational part and during the training sessions of 
the program, with the aim to increase exercise self-efficacy 
and motivate for long-term activity. A list of relevant leisure 
activities and exercise facilities near the participants’ homes 
were distributed at the end of intervention. Two patients, who 
were current smokers at baseline, were offered an individual 
smoking cessation intervention consisting of 16 individual 
sessions lasting 6 months.
Outcome measures
Outcomes were measured before and after the self- management 
program and 2 and 5 years after the start of the intervention. 
Self-reported exercise was asked for at year 5.
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Primary outcomes
Health-related quality of life (HRQoL) was assessed 
using St George’s Respiratory Questionnaire (SGRQ)16 
(the  Norwegian version).17 The SGRQ total score was the 
primary outcome; the domains “symptoms”, “activity”, and 
“impact” are also reported. The scores for all scales were 
weighted to range from 0–100, a score of 100 indicating worst 
health. A change of four units or more indicates a clinically 
significant change.18
A 6-minute walk test (6MWT) was used to measure 
“exercise capacity”.19,20 Performed indoor, the walking course 
was 45 m in length and the same technician carried out all 
the tests. A change of 54 m or more in walking distance is 
considered clinically relevant.21
Secondary outcomes
To measure “perception of breathlessness”, the Modified 
Borg Scale (MBS) was used during the 6MWT.20,22 MBS 
ranges from zero to ten, where zero is no problem. The 
 highest value, indicating maximum disability is reported.
Coping with breathlessness generally was assessed using 
Breathing Problems Questionnaire (BPQ) short version23 
(the Norwegian version).24 This version consists of ten 
items with a possible score between zero and 30 where zero 
indicates no problem.
“Self-efficacy” was measured using the COPD Self-
 Efficacy Scale (CSES).25 The Norwegian short form version 
(not validated) with 12 questions with a possible score between 
zero and 60, where zero indicates no problem, was used.
“Lung function” was measured with FVC (forced vital 
capacity) percentage predicted and FEV
1
 (forced expiratory 
volume in 1 second) percentage predicted.
To monitor “oxygenation” during 6MWT, we used pulse 
oximetry (SpO
2
) (Tuffsat, Datex-Ohmeda, Louisville, KY).
“Number of hospitalizations” and “days in hospital 
because of exacerbations” were taken from health records.
To measure whether the participants had continued to 
exercise during the follow-up time or not, the participants 
were asked face-to-face: “Have you exercised regularly, at 
least 30 minutes three times a week, since the end of the 
program?” And if “Yes”: “Have you mainly taken part in 
organized group exercise or have you mainly exercised on 
your own?” The participants were also asked to describe the 
type of exercise performed.
Analysis
The data are presented using descriptive statistics. Missing 
data for those who were lost to follow-up were replaced with 
the last recorded value carried forward. To test for changes 
over time, general linear model repeated measurement analy-
sis with Bonferroni adjustment for the confidence interval 
in SPSS for Windows (v 17.0; SPSS Inc, Chicago, IL) was 
used. An analysis of covariance (ANCOVA) was used to ana-
lyze differences between those who had exercised regularly 
after end of the program versus those who had not. To find 
covariates, a bivariate analysis between baseline values and 
participants exercising or not at year 5 was undertaken. The 
baseline values of variables that were significant (P , 0.05: 
SpO
2
 and FEV
1
 percentage predicted) were used as covariates 
together with the baseline value of the dependent variable. 
All data were analyzed using SPSS software.
Results
Of the 30 participants, two died during the intervention part 
of the study (2 and 11 months after start) and four died during 
the follow-up period (Figure 1). Causes of death were heart 
failure (two), cerebral infarct (two), and lung cancer (two). 
There were 24 patients remaining in the study at the end of 
year 5, and data were collected from all of them.
At baseline, the mean age of the patients was 67 years and 
47% were women (Table 1). The mean pre-bronchodilator 
FEV
1
 percentage predicted was 41.3, mean distance, 6MWT, 
was 411 m and their average SGRQ total score 58.0 points 
(Table 2). The participants were in Stage II to IV accord-
ing to the GOLD criteria.14 None of the patients were under 
long-term oxygen therapy nor treated with non-invasive 
ventilation (NIV).
Self-management group (SMG) (n = 30)
Died during the 1-year intervention period
n = 2 (heart failure, cerebral infarct)
Died during the 4-year follow-up period
n = 4 (heart failure, cerebral infarct, lung
cancer [2])
Tested after 5 years n = 24
(Analyzed n = 30)
Answered invitation (n = 30)
Included in study (n = 30)
Figure 1 Flow chart.
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As shown in a previous publication,15 during the 1-year 
self-management program, the participants significantly 
improved their HRQoL measured by SGRQ total score 
of –4.4 points (95% CI: –6.3 to –2.5, P , 0.001), but 
6MWT showed no change –7.0 m (95% CI: –16.3 to 2.3, 
P = 0.137). Other outcome measurements showing significant 
 improvements during the intervention were SGRQ subscale 
symptom (P = 0.001), SGRQ subscale impact (P , 0.001), 
self-efficacy measured by CSES (P , 0.001), and coping 
with breathlessness measured by BPQ total (P = 0.001). 
Changes in the other outcomes were not significant from 
baseline to year 1.
Long-term effects, pre-intervention  
to year 5
The long-term effects were measured for 5 years on aver-
age (60 months, range 55–67 months) after the start of the 
program for each participant. The two patients participating 
in the individual smoking-cessation program over 6 months 
stopped smoking and were still ex-smokers at the 5-year 
follow-up.
Neither the primary nor the secondary outcomes 
showed any significant changes from pre-intervention 
to year 5 (Table 2). The HRQoL measured with SGRQ 
total showed a change of 1.4 points (95% CI: –3.6 to 6.3, 
P = 0.580). Nine of the participants (38%) showed a clini-
cally  significant improvement (change in SGRQ total score 
above four points). Exercise capacity measured with 6MWT 
changed –10 m (95% CI: –27 to 8, P = 0.262) (Figure 2). 
Table 1 Baseline demographics of the participants in the 
self-management program
Characteristics Baseline
Age (mean, min/max, SD) 67.2 (53/83, 7.6)
Females (N, %) 14 (46.7)
Smoking 
 Current smokers (N, %) 
 Ex-smokers (N, %) 
 Year smoked (mean, SD) 
 Pack years (mean, SD)
 
2 (6.7) 
28 (93.3) 
26 (17) 
25 (22)
Education (N, %) 
 Compulsory school 
 Middle level 
 University
 
16 (53.3) 
8 (26.7) 
6 (20.0)
Notes: Values are mean for the whole group (standard deviation, SD) or numbers 
of persons (%). N = 30. See Table 2 for other baseline values.
Table 2 Number of participants and mean values (SE) at baseline and after 1 year (end of program), and at 2 and 5 years
Variablea Test times (N, mean [SE]) Is difference between test times significant  
(P , 0.05)?bBaseline 1 year 2 years 5 years
Participants (N) 30 28 28 24
SGrQ (total, points) 58.0 (1.6) 53.5 (1.5) 54.4 (1.4) 59.3 (1.8) Yes. From baseline to 1 year (0.000) and  
2 years (0.003) and from 1 year to 5 years (0.006)
6MWT (m) 411 (20.4) 404 (21.5) 399 (22.1) 402 (23.9) No
Borg score (highest during 
6MWT, points)
6.0 (0.2) 5.9 (0.2) 5.9 (0.2) 6.0 (0.2) No
BPQ (total points) 12.4 (0.6) 10.8 (0.5) 12.1 (0.5) 12.8 (0.7) Yes. From baseline to 1 year (0.001) and from  
1 year to 2 years (0.000) and 5 years (0.002)
CSES, points 36.5 (1.2) 28.9 (1.2) 35.0 (1.0) 34.9 (1.4) Yes. From baseline to 1 year (0.000) and from  
1 year to 2 years (0.000) and 5 years (0.000)
FEV1 (% predicted) 41.3 (2.2) 41.1 (2.3) 40.6 (2.2) 40.7 (2.3) Yes. From baseline to 2 years (0.000) and from  
1 year to 2 years (0.011)
FVC (% predicted) 74.4 (2.9) 74.3 (2.9) 74.0 (2.9) 74.5 (3.0) No
SpO2% rest 94.1 (0.4) 93.9 (0.4) 93.9 (0.4) 93.9 (0.4) No
Hospitalizations in last year 0.8 (0.2) 0.8 (0.3) 0.8 (0.3) 0.9 (0.3) No
Days in hospital in last year 4.0 (1.3) 4.0 (1.3) 3.8 (1.2) 4.8 (1.4) No
SGrQ (symptom, points) 51.1 (3.3) 41.2 (3.0) 42.8 (2.9) 48.1 (3.7) Yes. From baseline to 1 year (0.001)  
and 2 years (0.005)
SGrQ (activity, points) 83.6 (1.7) 83.0 (1.6) 84.3 (1.4) 82.4 (1.8) No
SGrQ (impact points) 45.8 (2.1) 40.7 (1.9) 40.8 (1.8) 49.3 (2.2) Yes. From baseline to 1 year (0.000) and  
2 years (0.001), from 1 year to 5 years (0.003),  
and from 2 to 5 years (0.001)
Notes: aHigher value indicates better outcome for 6MWT, FEV1% of predicted, FVC% of predicted, and SpO2 at rest. Lower value indicates better outcome for SGrQ total 
and SGrQ subscales (range 0–100), Borg score (range 0–10), BPQ (range 0–30), CSES (range 0–60); btested using general linear model repeated measurement analysis with 
Bonferroni confidence interval adjustment in SPSS for Windows (v 17.0). Values in brackets are the P value for the comparisons. N = 30 for all analyses, last recorded value 
carried forward for the six participants who died.
Abbreviations: 6MWT, 6-minute walk test; BPQ, breathing problem questionnaire; CSES, COPD self-efficacy scale; FEV1, forced expiratory volume in 1 second; 
FVC, forced vital capacity; SE, standard error; SpO2, pulse oximetry; SGrQ, St George’s respiratory Questionnaire.
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Three of the participants (13%) had a clinically relevant 
improvement (change in 6MWT above 54 m).
Fifteen (63%) of the participants, who were alive at 
year 5, reported that they had exercised regularly, at least 
30 minutes three times a week, for the last 4 years. Of these, 
12 had taken part in group activities such as dancing and/or 
endurance training with other patients with COPD. The other 
three had carried out supervised exercise performance training 
programs at a training center. Regular walking every day was 
reported to have become a habit among all who had continued 
to  exercise. Those who had stopped exercising after the end of 
the program, cited lack of social support, repeating exacerba-
tions, perceived frailty, and poor health as reasons.
Table 3 shows the difference between those who had 
continued to exercise or not, controlling for baseline values of 
SpO
2
, FEV
1
 percentage predicted, and the outcome  measure. 
Those who reported to have exercised on a regular basis had a 
statistically and clinically significantly better HRQoL (SGRQ 
total, estimated mean difference –12.7 points, 95% CI: –23.3 
to –2.1), but there were no changes for exercise capac-
ity (6MWT, estimated mean difference –19 m, 95% CI: 
–78 to 40). Those who exercised also did significantly better 
on SGRQ symptoms, SGRQ activity, BPQ total, number of 
hospitalizations, and number of days in hospital.
Discussion
Patients with COPD, who took part in a 1-year self-
 management program, had maintained their pre-intervention 
level of health-related quality of life and exercise capacity 
4 years after the completion of the program.
The strength of this study is the length of the follow-
up. A limitation is that the study is neither randomized nor 
controlled, and in this way we are unable to control to what 
degree our results are attributed to the program. Furthermore, 
we did not collect data on the activity performed at home 
regarding intensity and duration before start of the study. 
The data on sustained physical activity after the study was 
based on one general question. Because of this, we do not 
know whether the participants in our study were more or 
less active compared to the time before the intervention, or 
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Figure 2 Changes in St George’s respiratory Questionnaire (SGrQ) total score 
and meters walked during 6-minute walk test (6MWT) for those who continued to 
exercise after end of program (“Yes”) and those who did not (“No”).
Note: Numbers are mean values.
Table 3 Outcome at baseline and year 5 for those who had continued to exercise and those who had not exercised regularly after 
end of the program
Variablesa Continued to exercise after 
end of program (N = 15)
Did not continue to exercise 
after end of program (N = 9)
Estimated difference between  
groups at year 5b
Baseline 5 years Baseline 5 years Mean (95% CI) P value
SGrQ (total, points) 57.5 (8.3) 55.9 (7.3) 55.7 (10.6) 66.0 (12.2) –12.7 (–23.3 to –2.1)* 0.021
6MWT (m) 438 (102) 427 (117) 371 (89) 357 (133) –19 (–78 to 40) 0.510
Borg score (highest during  
6MWT, points)
6.0 (1.4) 5.5 (1.3) 5.8 (1.2) 6.4 (1.2) –1.2 (–2.5 to 0.1) 0.075
BPQ (total, points) 12.5 (2.9) 11.7 (2.4) 11.7 (3.6) 14.8 (4.9) –3.8 (–7.5 to 0.0)* 0.050
CSES, points 34.5 (6.2) 32.5 (6.1) 36.8 (4.9) 37.7 (9.2) –5.0 (–12.9 to 2.8) 0.195
FEV1% predicted 45.9(12.3) 45.7 (12.4) 35.3 (9.6) 34.1 (9.4) 41.8 (41.1 to 42.5) 0.081
FVC% predicted 74.4 (15.1) 74.8 (15.2) 73.7 (17.6) 73.3 (18.7) 74.3 (73.4 to 75.1) 0.967
SpO2% rest 95.5 (1.6) 94.9 (2.0) 93.2 (2.3) 93.4 (1.7) –0.4 (–1.4 to 0.5) 0.344
Hospitalizations last year (N) 0.8 (1.3) 0.3 (1.0) 0.4 (0.7) 1.3 (1.5) –1.5 (–2.8 to –0.1)* 0.034
Days in hospital last year (N) 4.2 (7.8) 1.9 (5.2) 2.9 (5.6) 8.2 (8.8) –9.6 (–16.4 to –2.7)* 0.009
SGrQ symptom, points 47.4 (16.3) 41.6 (16.2) 54.0 (20.7) 62.5 (21.2) –24.7 (–45.6 to –3.7)* 0.023
SGrQ activity, points 83.1 (9.0) 78.1 (8.4) 82.9 (11.0) 85.8 (8.8) –9.3 (–17.9 to –0.6)* 0.037
SGrQ impact, points 46.1 (10.6) 47.5 (10.8) 40.8 (13.4) 55.6 (14.7) –11.0 (–25.1 to 3.0) 0.118
Notes: aHigher value indicates better outcome for 6MWT, FEV1% predicted, FVC% predicted and SpO2 at rest. Lower values indicate better outcome for SGrQ total and 
SGrQ subscales (range 0–100), Borg score (range 0–10), BPQ (range 0–30), CSES (range 0–60); bANCOVA with the baseline values of SpO2, FEV1% predicted, and the 
dependent variable as the covariates. *P value , 0.05; values are means for the two groups.
Abbreviations: 6MWT, 6-minute walk test; BPQ, breathing problem questionnaire; CSES, COPD self-efficacy scale; FEV1, forced expiratory volume in 1 second; 
FVC, forced vital capacity; SD, standard deviation; SpO2, pulse oximetry; SGrQ, St Georges respiratory Questionnaire.
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whether they differed from the average patient with COPD. 
But what we can describe is that patients with COPD doing 
regular training perform better, and have a better HRQoL 
and self-perceived dyspnea.
Although the HRQoL was on the pre-intervention 
level 5 years after the start of the program, it had a decline 
from year 2 to year 5, a finding in line with the expected 
deterioration of health status.26 However, seen in a 5-year 
perspective, they had maintained their level of HRQoL, 
thus having postponed the expected extent of decline. 
 Furthermore, in this study the participants had a very steady 
exercise capacity throughout the 5 years. This is contrary to 
the expected decline in functional performance.27 Inactivity 
has been found to be an important cause of disease progres-
sion in COPD,28 and Redelmeier et al showed an expected 
reduction in  exercise capacity to a clinically relevant extent 
every 2 years for patients with COPD not participating in 
rehabilitation programs.21
All the participants in our study completed the interven-
tion15 and two out of three had continued regular exercising 
after the end of the study. These observations were encourag-
ing and contrary to findings in studies that have shown that 
many participants drop out during the program or discontinue 
the activity after the end of the intervention.29–31 Foglio 
et al32 showed that patients with COPD undergoing repeated 
pulmonary rehabilitation programs over a period of 7 years 
did not show any significant worsening in exercise tolerance 
and HRQoL. And Heppner et al6 found that physical activ-
ity, like walking, after completing pulmonary rehabilitation, 
was associated with slower declines in overall HRQoL and 
dyspnea, during activities of daily living. In this study, those 
with more severe COPD were less likely to exercise 4 years 
after the end of the program. Patients with more severe dis-
ease might need a more aggressive intervention to keep on 
exercising after the end of the program.
The sustained physical activity among such a large pro-
portion of the participants in our study is likely to be the main 
factor causing the positive long-term results. The question 
is therefore whether any of the things done in the program 
helped to achieve this. Based on reflections in hindsight, 
we think that in addition to the general content and length 
of the program, some factors in particular could contribute. 
Voluntary organizations and physiotherapists in private prac-
tice gave a short face-to-face presentation of their existing 
activities during the self-management program. This may 
have made it easier to contact and join other groups after the 
completion of the intervention. Positive attitudes regarding 
information of how to exercise and exercise  self-efficacy 
were focused in our intervention, both predictors that 
have been found to be of importance regarding successful 
maintenance and long-term activity.29 Our intervention also 
included individual action plans. Early detection of exacer-
bations followed by appropriate actions have showed lower 
hospitalization rates and have also been found to be important 
regarding regular physical activity compared to patients who 
do not seek treatment.33
As many of the patients with COPD are limited in terms 
of ventilation during work, learning how to cope with exer-
tional dyspnea during the exercise sessions may have made 
it easier to raise the general level of physical activity.34 The 
ability to discuss whatever they found important, both with 
the health care professionals and the other participants dur-
ing the program, could have given the participants a sense of 
group support and increased self-efficacy; both are predictors 
found to be related to motivation for self-care and further 
social participation.35 However, more information is needed 
about why participants continue to exercise long-term after 
self-management programs, especially how such programs 
influence style of life, and new personal and social habits.
Conclusion
In this study, patients with COPD participating in a 1-year 
self-management program with some training maintained 
their pre-intervention level of health and exercise tolerance 
4 years after the end of the program.
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